Leukotriene modifiers: What is their position in asthma therapy?

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 2, 1998, Pages 170-172

  Szefler, S J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MONTELUKAST; PRANLUKAST; ZAFIRLUKAST; ZILEUTON;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CORTICOSTEROID THERAPY; DRUG EFFECT; EDITORIAL; HUMAN; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031722140     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70081-8     Document Type: Editorial

References (16)

1. ST Holgate P Bradding AP Sampson Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy J Allergy Clin Immunol 98 1996 1 13
2. E Israel J Cohn L Dube JM Drazen Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial Zileuton Clinical Trial Group JAMA 275 1996 931 936
3. MC Liu LM Dube J Lancaster the Zileuton Study Group Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial J Allergy Clin Immunol 98 1996 859 871
4. SL Spector LJ Smith M Glass Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma ACCOLATE Asthma Trialists Group Am J Respir Crit Care Med 150 1994 618 623
5. B Knorr J Matz JA Bernstein H Nguyen BC Seidenberg TF Reiss Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial Pediatric Montelukast Study Group JAMA 279 1998 1181 1186
6. AL Hamilton I Faiferman P Stober RM Watson PM OByrne Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early and late phase bronchoconstruction and airway hyperresponsiveness in asthmatic subjects J Allergy Clin Immunol 102 1998 177 183
7. M Fujimura S Sakamoto Y Kamio T Matsuda Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma Respir Med 87 1993 133 138
8. F Taki R Suzuki K Torii S Matsumoto H Taniguchi K Takagi Reduction of the severity of bronchial hyperresponsiveness by the novel leukotriene antagonist 4-oxo-8-[4-(4-phenyl-butoxy)benzoylamino]-2-(tetrazol-5-yl)-4H-1-benzopyran hemihydrate Drug Res 44 1994 330 333
9. J Tamaoki M Kondo N Sakai J Nakata H Takemura A Nagai Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid The Tokyo Joshi-Idai Asthma Research Group Am J Respir Crit Care Med 155 1997 1235 1240
10. IK Taylor KM OShaughnessy RW Fuller CT Dollery Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects Lancet 337 1991 690 694
11. National Asthma Education 2 Prevention Program Expert Panel Report Guidelines for the Diagnosis and Management of Asthma 1997 National Institutes of Health, National Heart, Lung and Blood Institute Pub. No. 97-4051
12. L Agertoft S Pedersen Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children Respir Med 88 1994 373 381
13. PJ Barnes S Pedersen WW Busse Efficacy and safety of inhaled corticosteroids. New developments Am J Respir Crit Care Med 157 Pt 2 1998 S1 S53
14. D Olivieri A Chetta M Del Donno G Berorelli A Casalini A Pesci Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study Am J Respir Crit Care Med 155 1997 1864 1871
15. LM DuBuske J Grossman LM Dube LJ Swanson JF Lancaster the Zileuton Study Group Randomized trial in patients with moderate asthma: effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms Am J Managed Care 3 1997 633 640
16. KH In K Asano D Beier J Grobholz PW Finn ES Silverman Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription J Clin Invest 99 1997 1130 1137